R31

Hematuria

## Introduction to HematuriaUnspecified hematuria (R31) refers to the presence of blood in the urine where the specific cause, type (gross or microscopic), or origin is not yet determined or documented. Hematuria is a significant clinical finding that warrants thorough investigation as it can be a sign of various underlying conditions, ranging from benign to life-threatening. The term 'unspecified' indicates that further diagnostic workup is often required to identify the precise etiology and guide appropriate management. Hematuria can be broadly classified into gross (visible to the naked eye, leading to pink, red, or cola-colored urine) or microscopic (only detectable under a microscope, typically >3 red blood cells per high-power field in a centrifuged urine sample).## PathophysiologyThe presence of red blood cells in the urine can originate from any point along the urinary tract, from the kidneys to the urethral meatus. Pathophysiologically, hematuria can be categorized as glomerular or non-glomerular. Glomerular hematuria typically results from damage to the renal glomeruli, often seen in conditions like glomerulonephritis, and is characterized by dysmorphic red blood cells (irregularly shaped due to passage through damaged glomerular membranes) and red blood cell casts. Non-glomerular hematuria originates from other parts of the urinary tract (renal tubules, renal pelvis, ureters, bladder, urethra, prostate in males) and usually presents with isomorphic (normal-shaped) red blood cells. Potential mechanisms of bleeding include inflammation, infection, stone formation causing trauma to the urothelium, tumor invasion, vascular abnormalities, trauma, and certain systemic conditions affecting coagulation or renal integrity.## Clinical Presentation and Diagnostic ApproachWhile gross hematuria is self-evident, microscopic hematuria is often asymptomatic and discovered incidentally during routine urinalysis. When symptoms are present, they can vary widely depending on the underlying cause. Common associated symptoms may include dysuria (painful urination), urgency, frequency, flank pain, abdominal pain, fever, chills, or symptoms of anemia in cases of significant blood loss. In cases of unspecified hematuria, the diagnostic approach is crucial. Initial steps involve confirming hematuria through repeat urinalysis and microscopic examination. Differentiating glomerular from non-glomerular causes is critical, often involving evaluation of red blood cell morphology and proteinuria.A comprehensive workup for unspecified hematuria typically includes:### History and Physical ExaminationDetailed medical history, including medication use (e.g., anticoagulants, NSAIDs), recent infections, trauma, family history of kidney disease or stones, and travel history. A thorough physical examination may reveal signs of systemic disease, abdominal tenderness, or costovertebral angle tenderness.### Laboratory TestsBlood tests may include complete blood count (CBC) to check for anemia, renal function tests (serum creatinine, BUN) to assess kidney function, and coagulation studies if a bleeding disorder is suspected. Urine culture is essential to rule out urinary tract infection. Urine cytology may be performed to screen for malignancy, particularly in older patients or those with risk factors.### Imaging StudiesImaging is vital to identify structural abnormalities, stones, or tumors. Common imaging modalities include renal ultrasound, computed tomography (CT) urogram, or magnetic resonance imaging (MRI) of the genitourinary tract. These studies help visualize the kidneys, ureters, and bladder.### CystoscopyCystoscopy, an endoscopic procedure, is often recommended, especially in patients over 35-40 years old, smokers, or those with other risk factors for bladder cancer, to directly visualize the bladder and urethra for lesions.## Standard of CareThe management of unspecified hematuria revolves entirely around identifying and treating the underlying cause. If a treatable cause is found (e.g., UTI, kidney stones), specific therapy is initiated. For cases where no cause is identified after an initial comprehensive workup (idiopathic hematuria), especially microscopic hematuria, a period of watchful waiting and regular follow-up may be recommended. This follow-up typically includes repeat urinalysis, blood pressure monitoring, and sometimes repeat imaging or cystoscopy at intervals determined by the patient's risk factors and initial findings. Continued surveillance is essential due to the potential for late manifestation of a significant underlying condition, such as malignancy. Patients should be educated on the importance of reporting any new or worsening symptoms.

Clinical Symptoms

  • Visible blood in urine (gross hematuria)
  • Pink, red, or cola-colored urine
  • No visible symptoms (microscopic hematuria, often found incidentally)
  • Dysuria (painful urination)
  • Urgency or frequency of urination
  • Flank pain
  • Abdominal pain
  • Fever
  • Chills
  • Fatigue
  • Swelling (edema)
  • High blood pressure
  • Proteinuria (foamy urine)
  • Blood clots in urine

Common Causes

  • Urinary tract infections (UTIs)
  • Kidney stones (nephrolithiasis)
  • Bladder stones
  • Glomerulonephritis (e.g., IgA nephropathy, post-streptococcal glomerulonephritis, lupus nephritis)
  • Kidney diseases (e.g., polycystic kidney disease, end-stage renal disease)
  • Urinary tract cancer (e.g., bladder cancer, kidney cancer, prostate cancer)
  • Benign prostatic hyperplasia (BPH)
  • Trauma to the kidneys or urinary tract
  • Strenuous exercise (march hematuria)
  • Medications (e.g., anticoagulants, NSAIDs, cyclophosphamide)
  • Sickle cell trait or disease
  • Alport syndrome
  • Thin basement membrane disease
  • Vascular malformations in the kidney
  • Renal papillary necrosis
  • Tuberculosis of the urinary tract
  • Schistosomiasis
  • Radiation cystitis
  • Idiopathic hematuria (benign essential hematuria)
  • Bleeding disorders

Documentation & Coding Tips

Always specify if hematuria is gross or microscopic.

Example: Patient, 68M, presents with acute onset gross hematuria (R31.0), described as dark red urine, persistent for 2 days. No dysuria or fever, but reports recent fall with mild left flank pain. Urinalysis confirms numerous RBCs, no casts. Renal ultrasound shows mild left renal contusion. Suspect post-traumatic bleeding. This specificity (gross vs. microscopic) directly influences diagnostic urgency and CPT code selection for imaging/procedures. The traumatic origin links to potential HCC if associated with severe injury requiring hospitalization (e.g., S37.022A, initial encounter for left kidney laceration).

Billing Focus: Differentiates R31.0 (gross) from R31.1 (microscopic), impacting medical necessity for diagnostic procedures and often justifying higher E/M levels for initial assessment.

Document the definitive or suspected underlying cause of hematuria.

Example: Patient, 55F, with known history of recurrent nephrolithiasis, presents with acute onset right flank pain radiating to the groin and microscopic hematuria (R31.1). CT KUB reveals a 4mm calculus in the right distal ureter causing mild hydronephrosis. Diagnosis: Right ureteral calculus with obstruction and microscopic hematuria (N20.1, N13.2). Plan: Pain control, fluids, tamsulosin for stone passage. This documentation clearly links the hematuria to a specific, treatable cause, supporting billing for imaging (e.g., 74176 CT KUB) and management. The diagnosis of nephrolithiasis contributes to the patient's overall disease burden, and recurrent or obstructive stones may have HCC implications if associated with CKD.

Billing Focus: Directs coding to the definitive diagnosis (e.g., N20.x for calculus, N30.x for infection, C67.x for malignancy), which are higher specificity and often higher-value codes than R31 alone, justifying comprehensive workup.

Differentiate between transient, persistent, or recurrent hematuria.

Example: Patient, 42M, asymptomatic, had microscopic hematuria (R31.1) noted on a pre-employment physical urinalysis. Repeat urinalysis 6 weeks later is negative. Diagnosis: Transient microscopic hematuria. No further workup indicated at this time. Billing focuses on the transient nature, indicating lower clinical complexity compared to persistent hematuria, thus supporting less aggressive workup and potentially lower E/M levels. Risk adjustment impact is minimal unless a persistent, unresolved underlying cause (e.g., benign familial hematuria, N02.9) is ultimately confirmed requiring ongoing management.

Billing Focus: Impacts medical necessity for further diagnostic testing. Transient hematuria often requires less aggressive workup, potentially leading to lower complexity E/M services, whereas persistent/recurrent necessitates more extensive evaluation.

Document all associated symptoms and relevant comorbidities influencing the hematuria.

Example: Patient, 72M, with uncontrolled Type 2 Diabetes Mellitus (E11.9, HCC-qualifying) and known Stage 3 Chronic Kidney Disease (N18.3, HCC-qualifying), presents with new onset microscopic hematuria (R31.1), increased fatigue, and rising creatinine (current 3.8 mg/dL). Renal ultrasound shows increased echogenicity. Suspect worsening diabetic nephropathy (E11.22) and/or intrinsic renal pathology contributing to hematuria. Plan: Urgent Nephrology consult, review current medications including anticoagulants. Documentation of these comorbidities and their suspected influence on hematuria justifies higher E/M coding and accurately reflects the complex clinical scenario, significantly impacting risk adjustment for multiple chronic conditions.

Billing Focus: Supports medical necessity for comprehensive evaluation and management, allowing for higher E/M levels (e.g., 99215) when multiple comorbidities are actively addressed and impact the presenting symptom.

Specify the anatomical source of bleeding if clinically determined.

Example: Patient, 65F, with history of smoking, presents with painless gross hematuria (R31.0). Cystoscopy identified an actively bleeding papillary mass on the posterior bladder wall. Biopsy confirmed high-grade urothelial carcinoma (C67.4, Malignant neoplasm of posterior wall of bladder). Documentation of hematuria as 'gross, originating from posterior bladder wall mass' provides precise detail for billing and risk adjustment, clearly linking the symptom to the malignant process requiring complex intervention (e.g., TURBT CPT code 52240).

Billing Focus: Pinpointing the source (e.g., bladder, kidney, urethra) aids in selecting appropriate diagnostic and interventional CPT codes and linking them to specific ICD-10 anatomical sites for enhanced specificity and reimbursement.

Relevant CPT Codes

Related Diagnoses

Hierarchy